Drug Prohibition and Violence Jeffrey A
Total Page:16
File Type:pdf, Size:1020Kb

Load more
Recommended publications
-
Decriminalization of Personal Use of Psychoactive Substances
Decriminalization of Personal Use of Psychoactive Substances 2018 Position Statement Canadian Association of Social Workers Author: Canadian Association of Social Workers (CASW) - 2018 Page 1 ofColleen 7 Kennelly 2018 Position Statement This statement was originally written and released byCanadian the Canadian Public Associa Health tion of Social Workers Association. The Canadian Association of Social Workers reprints and adapts the original statement with permission. Founded in 1926, the Canadian Association of Social Workers (CASW) is the national association voice for the social work profession. CASW has adopted a pro-active approach to issues pertinent to social policy/social work. It produces and distributes timely information for its members, and special projects are initiated and sponsored. With its concern for social justice and its continued role in social advocacy, CASW is recognized and called upon both nationally and internationally for its social policy expertise. The mission of CASW is to promote the profession of social work in Canada and advance social justice. CASW is active in the International Federation of Social Workers (IFSW). Ce document est disponible en français Canadian Association of Social Workers (CASW) - 2018 Page 2 of 7 DECRIMINALIZATION OF PERSONAL USE OF PSYCHOACTIVE SUBSTANCES The use of illegal psychoactive substances (IPS) in Canada persists despite ongoing efforts to limit their consumption. Criminalization of those who use these substances remains the principal tool to control their use and is unsuccessful. An alternative approach – a public health approach – is required. Such an approach is being used to manage the ongoing opioid crisis through amendments to the Controlled Drugs and Substances Act and other related acts,1 including renewal of the Canadian Drugs and Substances Strategy. -
The Ethics of Psychedelic Medicine: a Case for the Reclassification of Psilocybin for Therapeutic Purposes
THE ETHICS OF PSYCHEDELIC MEDICINE: A CASE FOR THE RECLASSIFICATION OF PSILOCYBIN FOR THERAPEUTIC PURPOSES By Akansh Hans A thesis submitted to Johns Hopkins University in conformity with the requirements for the degree of Master of Bioethics Baltimore, Maryland May 2021 © 2021 Akansh Hans All Rights Reserved I. Abstract Our current therapeutic mental health paradigms have been unable to adequately handle the mental illness crisis we are facing. We ought to ‘use every tool in our toolbox’ to help individuals heal, and the tool we should be utilizing right now is Psilocybin. Although it is classified as a Schedule I drug, meaning that it is believed to have a high potential for abuse, no accepted medical uses, and a lack of safety when used under medical supervision, Psilocybin is not addictive and does not have a high potential for abuse when used safely under medical supervision. For these reasons alone, Psilocybin deserves a reclassification for therapeutic purposes. However, many individuals oppose Psilocybin-assisted psychotherapy on ethical grounds or due to societal concerns. These concerns include: a potential change in personal identity, a potential loss of human autonomy, issues of informed consent, safety, implications of potential increased recreational use, and distributive justice and fairness issues. Decriminalization, which is distinct from reclassification, means that individuals should not be incarcerated for the use of such plant medicines. This must happen first to stop racial and societal injustices from continuing as there are no inherently ‘good’ or ‘bad’ drugs. Rather, these substances are simply chemicals that humans have developed relationships with. As is shown in this thesis, the ethical implications and risks of psychedelic medicine can be adequately addressed and balanced, and the benefits of Psilocybin as a healing tool far outweigh the risks. -
Legalization and Decriminalization of Cannabis |
AMERICAN MEDICAL ASSOCIATION YOUNG PHYSICIANS SECTION Resolution: 5 (A-19) Introduced by: Albert L. Hsu, MD Subject: Public Health Impacts and Unintended Consequences of Legalization and Decriminalization of Cannabis for Medicinal and Recreational Use Referred to: AMA-YPS Reference Committee 1 Whereas, AMA Policy D-95.969, “Cannabis Legalization for Medicinal Use,” states, in part, that 2 our AMA: “(2) believes that cannabis for medicinal use should not be legalized through the state 3 legislative, ballot initiative, or referendum process;” and 4 5 Whereas, AMA Policy H-95.924, “Cannabis Legalization for Recreational Use,” states, in part, 6 that our AMA: “(5) encourages local, state, and federal public health agencies to improve 7 surveillance efforts to ensure data is available on the short- and long-term health effects of 8 cannabis use;” and 9 10 Whereas, AMA Policy H-95.923, “Taxes on Cannabis Products,” states that “our AMA 11 encourages states and territories to allocate a substantial portion of their cannabis tax revenue 12 for public health purposes, including: substance abuse prevention and treatment programs, 13 cannabis-related educational campaigns, scientifically rigorous research on the health effects of 14 cannabis, and public health surveillance efforts;” and 15 16 Whereas, AMA Policy H-95.952, “Cannabis and Cannabinoid Research,” states, in part, that our 17 AMA: “(4) supports research to determine the consequences of long-term cannabis use, 18 especially among youth, adolescents, pregnant women, and women who are breastfeeding; -
Black Market Peso Exchange As a Mechanism to Place Substantial Amounts of Currency from U.S
United States Department of the Treasury Financial Crimes Enforcement Network FinCEN Advisory Subject: This advisory is provided to alert banks and other depository institutions Colombian to a large-scale, complex money laundering system being used extensively by Black Market Colombian drug cartels to launder the proceeds of narcotics sales. This Peso Exchange system is affecting both U.S. financial depository institutions and many U.S. businesses. The information contained in this advisory is intended to help explain how this money laundering system works so that U.S. financial institutions and businesses can take steps to help law enforcement counter it. Overview Date: November Drug sales in the United States are estimated by the Office of National 1997 Drug Control Policy to generate $57.3 billion annually, and most of these transactions are in cash. Through concerted efforts by the Congress and the Executive branch, laws and regulatory actions have made the movement of this cash a significant problem for the drug cartels. America’s banks have effective systems to report large cash transactions and report suspicious or Advisory: unusual activity to appropriate authorities. As a result of these successes, the Issue 9 placement of large amounts of cash into U.S. financial institutions has created vulnerabilities for the drug organizations and cartels. Efforts to avoid report- ing requirements by structuring transactions at levels well below the $10,000 limit or camouflage the proceeds in otherwise legitimate activity are continu- ing. Drug cartels are also being forced to devise creative ways to smuggle the cash out of the country. This advisory discusses a primary money laundering system used by Colombian drug cartels. -
Rethinking America's Illegal Drug Policy
NBER WORKING PAPER SERIES RETHINKING AMERICA'S ILLEGAL DRUG POLICY John J. Donohue III Benjamin Ewing David Peloquin Working Paper 16776 http://www.nber.org/papers/w16776 NATIONAL BUREAU OF ECONOMIC RESEARCH 1050 Massachusetts Avenue Cambridge, MA 02138 February 2011 The authors wish to thank Jonathan Caulkins, Phil Cook, Louis Kaplow, Rob MacCoun, Jeffrey Miron, Peter Reuter, and participants at two NBER conferences and the Harvard Law School Law and Economics workshop for valuable comments. We are also particularly grateful to Jeffrey Miron and Angela Dills for sharing their national time series data on drug prohibition enforcement and crime. The views expressed herein are those of the authors and do not necessarily reflect the views of the National Bureau of Economic Research. © 2011 by John J. Donohue III, Benjamin Ewing, and David Peloquin. All rights reserved. Short sections of text, not to exceed two paragraphs, may be quoted without explicit permission provided that full credit, including © notice, is given to the source. Rethinking America's Illegal Drug Policy John J. Donohue III, Benjamin Ewing, and David Peloquin NBER Working Paper No. 16776 February 2011, Revised March 2011 JEL No. K0 ABSTRACT This paper provides a critical review of the empirical and theoretical literatures on illegal drug policy, including cross-country comparisons, in order to evaluate three drug policy regimes: criminalization, legalization and “depenalization.” Drawing on the experiences of various states, as well as countries such as Portugal and the Netherlands, the paper attempts to identify cost-minimizing policies for marijuana and cocaine by assessing the differing ways in which the various drug regimes would likely change the magnitude and composition of the social costs of each drug. -
An Examination of the Legal Marijuana Use Age and Its Enforcement in California, a State Where Recreational Marijuana Is Legal
An examination of the legal marijuana use age and its enforcement in California, a state where recreational marijuana is legal March 2021 James C. Fell NORC at the University of Chicago Traci Toomey University of Minnesota Angela H. Eichelberger Insurance Institute for Highway Safety Julie Kubelka NORC at the University of Chicago Daniel Schriemer Darin Erickson University of Minnesota Contents ABSTRACT .................................................................................................................................................. 3 INTRODUCTION ........................................................................................................................................ 4 METHOD ..................................................................................................................................................... 6 Enforcement of minimum legal marijuana use age of 21 (MLMU-21) laws ...................................... 6 Pseudo-underage patron entry attempts ............................................................................................... 7 Sample design ............................................................................................................................ 8 Recruitment of pseudo-underage patrons ................................................................................. 9 Data collection protocol ............................................................................................................ 9 RESULTS .................................................................................................................................................. -
Decriminalization of Marijuana and Potential Impact on CMV Drivers
Commercial Vehicle Safety Research Summit Decriminalization of Marijuana and Potential Impact on CMV Drivers Darrin T. Grondel, Director Washington Traffic Safety Commission November 09, 2016 Collaboration and Research SIGNS AND SYMPTOMS OF MJ IMPAIRMENT THC and similar compounds bind with receptors (CB1 and CB2) in the brain and other parts of the body affecting the function of the hippocampus (short-term memory), cerebellum (coordination) and basal ganglia (unconscious muscle movements). • Marijuana is a lipid (fat) soluble and tends to stay in the brain • Alcohol is water soluble - blood Reference - http://www.brainwaves.com/ SIGNS AND SYMPTOMS OF MARIJUANA Relaxation Mood changes, including Euphoria panic and paranoia with high dose Relaxed Inhibitions Heightened senses Disorientation Body tremors (Major Altered time & distance muscle groups: quads, perception gluts, and abs) Lack of Concentration Eyelid tremors Impaired Memory & Red, Bloodshot eyes comprehension Possible GVM or green Jumbled thought coating on tongue formation Dilated pupils Drowsiness CHALLENGES AND IMPACTS ON CMV Data – lack of good data on CMV crashes with DRE in WA and Nationally. Public indifference on the issue of drugged driving vs. Alcohol impairment Medical Marijuana– have all states adopted federal rules for Intrastate CMV operators? 49 CFR 382.60 – Supervisors required to attend 60 min of training for symptoms of alcohol abuse and another 60 min for controlled substances. A singular event no refresher. Is this enough? Refresher? Compare to LE? This training should have considerations for expansion with high prevalence of drugged driving. CVEO – trained in signs and symptoms (ARIDE or modified DRE). Can they identify potentially impaired drivers? National studies are focused on PV with little to no attention on CMV operators. -
Marijuana: What the Evidence Shows at It Relates to the Impact of Use and What Can Be Learned from Washington State and Colorado.”
Kevin A. Sabet, Ph.D. Director, University of Florida Drug Policy Institute, Department of Psychiatry, Division of Addiction Medicine Director, Project SAM (Smart Approaches to Marijuana) Author, Reefer Sanity: Seven Great Myths About Marijuana Before the House and Senate Judiciary Committees, State of Oregon January 17, 2013 Written Testimony “Marijuana: What the evidence shows at it relates to the impact of use and what can be learned from Washington State and Colorado.” Chairman and distinguished members of the Committee, thank you for providing me with the opportunity to appear before you today to discuss marijuana policy and appropriate federal responses. I have studied, researched, and written about drug policy, drug markets, drug prevention, drug treatment, criminal justice policy, addiction, and public policy analysis for almost 18 years. Most recently, from 2009-2011, I served in the Obama Administration as a senior drug policy advisor. I am currently the co-founder, with former Congressman Patrick J. Kennedy, of Project SAM (Smart Approaches to Marijuana). I am also the author of Reefer Sanity: Seven Great Myths About Marijuana (Beaufort). In fact, in my new book, I outline the precise reasons why we in the Obama Administration rejected legalization time and time again when presented with it. Our experience, when talking with parents, prevention and treatment providers, medical associations, law enforcement, and others, was that opening up a legal market for any current illicit drug would be disastrous for public health and safety. Indeed, in the Obama Administration’s inaugural and subsequent drug control strategies, marijuana legalization is explicitly rejected. That is why numerous groups and I found the recent guidance by the U.S. -
(00:10): [Inaudible]
Speaker 1 (00:10): [inaudible] Speaker 2 (00:11): Hello and welcome to the higher enlightenment podcast brought to you by higher yields cannabis consulting, your seed to sale cannabis business solutions team, and the creators of the innovative cannabis consulting business solution system higher enlightenment. My name is Adam. I'm your host and part of the creative design team here at higher yields. Today's podcast is about decriminalization versus legalization. Let's start by having our panel of experts. Introduce themselves. Let's start with you, Chris. Could you tell us a little bit about your background and what you do? Speaker 1 (00:50): My name is Chris Teegarden. I'm the former mayor of Edgewater, Colorado, the first municipality in the world to codify and regulate recreational cannabis. I am the director of government affairs for higher yields consulting, a vertically integrated cannabis consulting company. Uh, while I was out in Denver as a mayor, uh, I also was vice chair of the first judicial criminal justice coordinating committee, uh, which encompassed two counties in the Denver Metro area and served about 600,000 people. And we were doing high level policy initiatives, uh, for that area and direct, uh, collaboration and working with the federal state and local jurisdictions. I was also the chair of the Metro mayor's caucus, homelessness and hunger committee, and the Metro mayor's caucus was a gathering and group of 42 mayors and the front range region talking about high level policy on many initiatives and criminal justice was also one of those initiatives. -
Exploring Inequality
SMU McLane/Armentrout/Bridwell Scholars Reading Groups Fall 2020 Syllabus Exploring Inequality Tues./Wed.: Dean Stansel, Ph.D., Senior Research Fellow [email protected], office: 214-768-3492 Mon./Fri.: Meg Tuszynski, Ph.D., Research Fellow & Assistant Director [email protected], office: 214-768-3170 O’Neil Center for Global Markets & Freedom (www.oneilcenter.org) Cox School of Business, Crow 282 Meeting Times. Our meetings will be held on Mondays (Bridwell), Tuesdays (McLane), and Wednesdays (Armentrout) at 6-7 pm (Central time), and Fridays (Armentrout) at 11am-noon (Central time) online via Zoom. All four groups have the same readings. Attendance is required. Your attendance and active participation are required. We will have 10 regular meetings plus a joint reading group summit with the students from similar reading groups at Baylor, Texas Tech, Angelo State, and University of Central Arkansas. That event will be held online via Zoom on the morning of Sat. Oct. 17 and is a required part of the program. You will not be paid the $1000 stipend if you do not attend. You are required to attend all 10 weekly meetings. However, if you have an unavoidable conflict, we do have limited flexibility, with advance notice, for you to switch nights if you cannot attend on your regular reading group night (i.e., if you can’t make one of your regular Monday night meetings, you can instead attend on Tuesday, Wednesday, or Friday that week and vice-versa). In addition, the O’Neil Center hosts several guest speakers throughout the semester. Those will all be online this semester. -
Forbidden Transactions and Black Markets
Forbidden Transactions and Black Markets Chenlin Gu,∗ Alvin E. Roth,y and Qingyun Wuzx Abstract Repugnant transactions are sometimes banned, but legal bans sometimes give rise to active black markets that are difficult if not impossible to extinguish. We explore a model in which the probability of extinguishing a black market depends on the extent to which its transactions are regarded as repugnant, as measured by the proportion of the population that disapproves of them, and the intensity of that repugnance, as measured by willingness to punish. Sufficiently repugnant markets can be extinguished with even mild punishments, while others are insuf- ficiently repugnant for this, and become exponentially more difficult to extinguish the larger they become. (JEL D47, K42, P16) Keywords: black market; repugnance; Markov process. 1 Introduction Why are drug dealers plentiful, but hitmen scarce? I.e. why is it relatively easy for a newcomer to the market to buy illegal drugs, but hard to hire a killer? Both of those transactions come with harsh criminal penalties, vigorously enforced: In the U.S., half of Federal prisoners have drug convictions,1 and murder for hire is treated ∗DMA, Ecole Normale Sup´erieure,PSL Research University, Paris 75230, France (email: chen- [email protected]). yDepartment of Economics, Stanford University, Stanford, CA 94305, United States (email: al- [email protected]). zDepartment of Economics, and Department of Management Science and Engineering, Stanford University, Stanford, CA 94305, United States (email: [email protected]). xWe thank Itai Ashlagi, Fuhito Kojima, Jean-Christophe Mourrat, Muriel Niederle, Andrei Shleifer, Gavin Wright, Zeyu Zheng and Zhengyuan Zhou for helpful discussions. -
House Plans Historic Vote on Federal Marijuana Legalization
Legal Sidebari The MORE Act: House Plans Historic Vote on Federal Marijuana Legalization November 25, 2020 In December 2020, the House of Representatives plans to vote on H.R. 3884, the Marijuana Opportunity Reinvestment and Expungement Act of 2019 (MORE Act). The MORE Act is also pending before the Senate. Among other things, the MORE Act would remove marijuana from the schedules of controlled substances under the Controlled Substances Act (CSA), legalizing many marijuana-related activities at the federal level. Commentators have noted that a vote on the MORE Act would be the first time the full House voted on a proposal to deschedule marijuana. This Legal Sidebar briefly summarizes the legal status of marijuana in the United States. It then outlines key provisions of the MORE Act before discussing selected considerations for Congress related to the bill. The Legal Status of Marijuana Under federal law, the plant Cannabis sativa L. and products derived from that plant are generally classified as marijuana, with a couple of exceptions. (The statute uses an archaic spelling, “marihuana,” that was more common when Congress enacted the CSA in 1970, but this Sidebar uses the currently accepted spelling, “marijuana.”) One key exception relates to hemp, a legal classification that includes cannabis and cannabis-derived products containing very low levels of the psychoactive cannabinoid delta- 9 tetrahydrocannabinol (THC). Hemp is not a controlled substance subject to the CSA, though it remains subject to other federal laws. Congress classified marijuana as a Schedule I controlled substance when it enacted the CSA, meaning that marijuana is subject to the most stringent level of federal control.